Skip to main content

NU SKIN ENTERPRISES, INC.

corporate_fare Company Profile

NU SKIN ENTERPRISES, INC.

NUS·NYSE·Trade & Services·CIK 0001021561

Nu Skin Enterprises, Inc. develops and distributes a comprehensive line of premium-quality beauty and wellness solutions in nearly 50 markets worldwide. In 2025, the company generated $1.5 billion in revenue, primarily from its beauty products and wellness products. Nu Skin operates in the direct selling channel, using person-to-person marketing, including social and digital platforms, to promote and sell its products. Beyond its core Nu Skin business, the company explores new areas of synergistic and adjacent growth through its strategic investment arm, Rhyz Inc., formed in 2018. Rhyz businesses primarily consist of consumer, technology, and manufacturing companies. In 2025, the Rhyz companies generated $223.6 million, representing 15% of Nu Skin's 2025 reported revenue (excluding sales to the core Nu Skin business). In January 2025, Nu Skin sold one Rhyz business that accounted for $69.6 million of its 2024 reported revenue. The Rhyz companies aim to optimize cost of goods, improve lead times, diversify revenue mix, and create synergies for Nu Skin's brands. In 2025, approximately 26% of Nu Skin's revenue came from the United States (comprising Nu Skin United States and Rhyz businesses), with the remainder from international markets. In 2025, foreign-currency fluctuations negatively impacted the company's revenue by 0.8% compared to 2024. Nu Skin offers a branded, award-winning, and differentiated product portfolio.

NU SKIN ENTERPRISES, INC. (NYSE:NUS) is a publicly traded company in the Trade & Services sector. Wiseek monitors NUS SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Nu Skin Stockholders Approve Incentive Plan, Authorizing 2.85M New Shares
  • Stockholders Approve 2.85 Million Share Increase for Omnibus Incentive Plan
  • Executive VP & Chief Product Officer Resigns, Transitions to Advisor Role
  • Nu Skin Reports Steep Q1 Revenue & EPS Decline, Restructures Debt with Reduced Facilities
  • Nu Skin Reports Significant Q1 Revenue and EPS Decline, Maintains Negative Full-Year Outlook

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
1.49B
Net Income
160.2M
Diluted EPS
3.18
Op. Cash Flow
80.29M
Free Cash Flow
46.01M
Gross Profit
1.03B
Operating Income
65.76M
Cash & Equivalents
238.63M
Total Debt
224.19M
Debt / Equity
0.28×
Net Margin
10.8%
Shares Outstanding
49.29M sh
Source: 10-K · filed 2026-02-13 · accession 0001140361-26-005130
Browse all tickers starting with N →
$5.47
52-week range · as of 2026-05-29 $5.62 – $14.62
Market cap
$265.57M
Volume
521.2K (0.8× avg)
3-mo avg 682.3K
Live data · 2026-06-14 05:13 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed NUS - Latest Insights

NUS
May 29, 2026, 4:10 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $5.79
Real-time Price: $5.47 info
Change: -$0.320 (-6%) info
Market Cap: $265.571M info
NUS
May 29, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.79
Real-time Price: $5.47 info
Change: -$0.320 (-6%) info
Market Cap: $265.571M info
NUS
May 08, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.16
Real-time Price: $5.47 info
Change: -$1.69 (-24%) info
Market Cap: $265.571M info
NUS
May 07, 2026, 8:04 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $6.74
Real-time Price: $5.47 info
Change: -$1.27 (-19%) info
Market Cap: $265.571M info
NUS
May 07, 2026, 5:09 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.80
Real-time Price: $5.47 info
Change: -$1.33 (-20%) info
Market Cap: $265.571M info
NUS
May 07, 2026, 4:07 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $6.81
Real-time Price: $5.47 info
Change: -$1.34 (-20%) info
Market Cap: $265.571M info
NUS
Apr 03, 2026, 2:28 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $7.41
Real-time Price: $5.47 info
Change: -$1.94 (-26%) info
Market Cap: $265.571M info
NUS
Mar 27, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $7.15
Real-time Price: $5.47 info
Change: -$1.68 (-23%) info
Market Cap: $265.571M info
NUS
Mar 27, 2026, 4:34 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $7.20
Real-time Price: $5.47 info
Change: -$1.73 (-24%) info
Market Cap: $265.571M info
NUS
Mar 20, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.10
Real-time Price: $5.47 info
Change: -$1.63 (-23%) info
Market Cap: $265.571M info
NUS
Mar 09, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $7.60
Real-time Price: $5.47 info
Change: -$2.13 (-28%) info
Market Cap: $265.571M info
NUS
Feb 12, 2026, 9:49 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $8.49
Real-time Price: $5.47 info
Change: -$3.02 (-36%) info
Market Cap: $265.571M info
NUS
Feb 12, 2026, 4:23 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.60
Real-time Price: $5.47 info
Change: -$3.13 (-36%) info
Market Cap: $265.571M info